AGP Picks
View all

Airline Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Airline Press Releases.

Press releases published on September 29, 2026

Bridge The Gaps Welcomes United Airlines Captain and Youth Mentor Marcus Salem to Board of Directors
EPISODE 3 OUT NOW: THE CREATURE’S TRAIL DEEPENS IN ‘FLIGHT OF THE FALLEN’
Ramparts Officially Designated as an Authorized C3PAO by The Cyber AB
575% Growth by 2030: Azilen Highlights the Data Challenge Behind Physical AI in Manufacturing
Business Travel Powers Economic Impact and Growth Across the World’s Leading Business Cities, According to GBTA Study
Sightline Intelligence & DEVCOM Aviation and Missile Center (AvMC) Partner on AI-Powered Target Acquisition and Tracking
BioPREVAIL and CEPI launch global Biosecurity Innovation Challenge to support 100 Days Mission
From Hash Balls to Diamond Powder: 6 Silly Nice Products NYC Visitors Should Know
Namib Minerals Secures US$6.5 Million Term Loan Facility to Partially Fund Resource Definition and Bankability
Coastal Community Bank earns Silver in Best Bank Category, Highlights Community Support
Results of FireFly’s Share Purchase Plan
Accelevation Announces Pricing of Initial Public Offering
FAIR AND FOWL 2026 FINDS CAGE-FREE SOURCING IS NOW STANDARD PRACTICE AS CORPORATE HOLDOUTS DWINDLE
Australian businesses risk losing more than AU$3 billion a year to payment failures
HII Wins U.S. Navy Contract for 10 ROMULUS USVs, Accelerating Deployment of Proven Autonomous Capability
DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years
DBV Technologies annonce le dépôt de sa demande de licence biologique (BLA) auprès de la Food and Drug Administration des Etats-Unis pour le patch VIASKIN® Peanut destiné aux enfants âgés de 4 à 7 ans.
Texas Data Center Site Selection Shifts Toward Power First Development
Wallbridge Mining Announces Voting Results from Special Meeting of Shareholders
Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and announces publication of trial results in The Lancet Diabetes & Endocrinology

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Airline Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.